Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print September 25, 2003, doi: 10.1161/01.RES.0000097262.21507.DF
A more recent version of this article appeared on October 17, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/8/697    most recent
01.RES.0000097262.21507.DFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, S. P.
Right arrow Articles by Marbán, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, S. P.
Right arrow Articles by Marbán, E.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Apoptosis
Right arrow Pathophysiology
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

Submitted on June 6, 2003
Revised on August 12, 2003
Accepted on September 11, 2003

Simvastatin Attenuates Oxidant-Induced Mitochondrial Dysfunction in Cardiac Myocytes

Steven P. Jones ; Yasushi Teshima ; Masaharu Akao ; and Eduardo Marbán *

From the Institute of Molecular Cardiobiology, The Johns Hopkins University School of Medicine, Baltimore, Md.

* To whom correspondence should be addressed. E-mail: marban{at}jhmi.edu.


Key words: mitochondria • statins • myocytes • nitric oxide • preconditioning




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. A. Ngoh, T. Hamid, S. D. Prabhu, and S. P. Jones
O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1711 - H1719.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. A. Ngoh, H. T. Facundo, T. Hamid, W. Dillmann, N. E. Zachara, and S. P. Jones
Unique Hexosaminidase Reduces Metabolic Survival Signal and Sensitizes Cardiac Myocytes to Hypoxia/Reoxygenation Injury
Circ. Res., January 2, 2009; 104(1): 41 - 49.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
K. Zhou, L. Zhang, J. Xi, W. Tian, and Z. Xu
Ethanol Prevents Oxidant-Induced Mitochondrial Permeability Transition Pore Opening in Cardiac Cells
Alcohol Alcohol., January 1, 2009; 44(1): 20 - 24.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Schmidinger, C. C. Zielinski, U. M. Vogl, A. Bojic, M. Bojic, C. Schukro, M. Ruhsam, M. Hejna, and H. Schmidinger
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
J. Clin. Oncol., November 10, 2008; 26(32): 5204 - 5212.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. P. Jones, N. E. Zachara, G. A. Ngoh, B. G. Hill, Y. Teshima, A. Bhatnagar, G. W. Hart, and E. Marban
Cardioprotection by N-Acetylglucosamine Linkage to Cellular Proteins
Circulation, March 4, 2008; 117(9): 1172 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Hauck, C. Harms, D. Grothe, J. An, K. Gertz, G. Kronenberg, R. Dietz, M. Endres, and R. von Harsdorf
Critical Role for FoxO3a-Dependent Regulation of p21CIP1/WAF1 in Response to Statin Signaling in Cardiac Myocytes
Circ. Res., January 5, 2007; 100(1): 50 - 60.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. H. Patel, B. P. Head, H. N. Petersen, I. R. Niesman, D. Huang, G. J. Gross, P. A. Insel, and D. M. Roth
Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and {delta}-opioid receptors
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H344 - H350.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. D.M. Engelmann and J. H. Svendsen
Inflammation in the genesis and perpetuation of atrial fibrillation
Eur. Heart J., October 2, 2005; 26(20): 2083 - 2092.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ito, T. Adachi, D. R. Pimentel, Y. Ido, and W. S. Colucci
Statins Inhibit {beta}-Adrenergic Receptor-Stimulated Apoptosis in Adult Rat Ventricular Myocytes via a Rac1-Dependent Mechanism
Circulation, July 27, 2004; 110(4): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J.-H. Bae, E. Bassenge, K.-Y. Kim, Y.-C. Synn, k.-R. Park, and M. Schwemmer
Effects of Low-Dose Atorvastatin on Vascular Responses in Patients Undergoing Percutaneous Coronary Intervention With Stenting
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 185 - 192.
[Abstract] [PDF]


Home page
Circ. Res.Home page
C. Patterson, M. S. Runge, and N. Madamanchi
Younger Than Yesterday: Is Vascular Senescence a Two-Way Street?
Circ. Res., April 2, 2004; 94(6): 703 - 705.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Kumagai, H. Nakashima, and K. Saku
The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model
Cardiovasc Res, April 1, 2004; 62(1): 105 - 111.
[Abstract] [Full Text] [PDF]